Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Milad Baroud"'
Autor:
Milad Baroud, Elise Lepeltier, Yolla El-Makhour, Nolwenn Lautram, Jerome Bejaud, Sylvain Thepot, Olivier Duval
Publikováno v:
Pharmaceuticals, Vol 14, Iss 12, p 1317 (2021)
5-Azacitidine, a cytidine analogue used as a hypomethylating agent, is one of the main drugs for the treatment of myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML) in the elderly. However, after administration, it exhibits several lim
Externí odkaz:
https://doaj.org/article/b21738572f654089beb9c95d5a35e179
Autor:
Duval, Milad Baroud, Elise Lepeltier, Yolla El-Makhour, Nolwenn Lautram, Jerome Bejaud, Sylvain Thepot, Olivier
Publikováno v:
Pharmaceuticals; Volume 14; Issue 12; Pages: 1317
5-Azacitidine, a cytidine analogue used as a hypomethylating agent, is one of the main drugs for the treatment of myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML) in the elderly. However, after administration, it exhibits several lim
Publikováno v:
Nanoscale Advances
Nanoscale Advances, RSC, 2021, 3 (8), pp.2157-2179. ⟨10.1039/d0na01084g⟩
Nanoscale Advances, 2021, 3 (8), pp.2157-2179. ⟨10.1039/d0na01084g⟩
Nanoscale Advances, RSC, 2021, 3 (8), pp.2157-2179. ⟨10.1039/d0na01084g⟩
Nanoscale Advances, 2021, 3 (8), pp.2157-2179. ⟨10.1039/d0na01084g⟩
International audience; Nucleoside and nucleotide analogs are essential tools in our limited arsenal in the fight against cancer. However, these structures face severe drawbacks such as rapid plasma degradation or hydrophilicity, limiting their clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2118cd0e5df5bcfbdf79e618129ed9cd
https://hal.univ-angers.fr/hal-03448613/document
https://hal.univ-angers.fr/hal-03448613/document